Augmentin

Not a healthcare professional? Visit our Public site

By proceeding, you are confirming that you are a Malta Healthcare Professional. The site contains promotional material.

For Healthcare Professionals

The site contains promotional material.

Report adverse event

Menu

Close

Profile

| Login Register

Basket

User logged in

Overlay Text

Visit our Public site

Report adverse event

Menu

Close

Event Registration successful

You now have sucesfully register for the event and you can also access to the latest updates, events and resources.

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

In case you would like to receive SMS-reminders for the event you have registered, please update scroll down to provide your consent and mobile number.

Account activated – pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next 3 working days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website

Event registration completed - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We'll send you and email with the result of the validation process in the next 3 working days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

Account activated - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next 3 working days.

In the meantime, you can enjoy the public content on our website

Event Account activated - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next 3 working days.

In the meantime, you can enjoy the public content on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

already registered

X »

$previewUrl

Anoro Ellipta 20 mcg

has been lorem added to your basket

View Basket

Content Path:/content/cf-pharma/health-hcpportal/en_MT/hcp/home

You are now leaving GSK Malta Health Portal

You are about to leave a GSK Website. By clicking this link, you will be taken to an external website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on this site. If you do not wish to leave this website, click on “Go Back” below:

Continue

Go back

MLT_GIB/OTH/0007/17m
Date of preparation: March 2018

Popup

Product overview

Augmentin (amoxicillin-clavulanate) is indicated for short-term treatment of bacterial infections caused by susceptible organisms.

Indications

Wide range of indications

Augmentin has a notably broad spectrum of activity against the commonly occurring bacterial pathogens in general practice and hospital.

Find out more

Efficacy

For short-term treatment of bacterial infections

Amoxicillin-clavulanate has shown efficacy in the treatment of acute bacterial rhinosinusitis (ABRS) and acute otitis media (AOM).

Learn more

Dosing & administration

Available in different strengths and forms

Several different strengths and ratios of oral amoxicillin-clavulanate are locally available.

Learn more

Video player requires JavaScript enabled. You can download this video here: https://gskvideo.edgesuite.net/HealthSites/Health/Malta/HCP/MP4/products/GSKDC-MLG-Video-2017-22941_Augumentin%20Malta%20Video_d2.mp4

Augmentin Portfolio

Over 30 years’ experience

With over 30 years of experience, Augmentin is consumed by millions of patients every year around the world. Over the years, the ratio of amoxicillin to clavulanic acid has been varied to reflect prescribing needs, to improve dosing convenience, and as a response to recommendations for the treatment of more severe infections or those caused by resistant organisms.

Watch the video

Video player requires JavaScript enabled. You can download this video here: https://gskvideo.edgesuite.net/HealthSites/Health/Malta/HCP/MP4/MT_9339061_Introduction_Dr_Gudrun_Maechler_Final_D1.mp4 https://gskvideo.edgesuite.net/HealthSites/Health/Malta/HCP/WEBM/MT_9339061_Introduction_Dr_Gudrun_Maechler_Final_D1.webm https://gskvideo.edgesuite.net/HealthSites/Health/Malta/HCP/OGV/MT_9339061_Introduction_Dr_Gudrun_Maechler_Final_D1.ogv

Antimicrobial Resistance

Appropriate antibiotic prescribing

Antimicrobial resistance (AMR) is recognised by the WHO as a serious global public health threat requiring immediate action. GSK is committed to combating AMR and supports numerous initiatives towards achieving this goal. Watch the video to learn more about the principles of appropriate prescribing to reduce AMR.

Watch the video

Augmentin is a registered trademark of the GlaxoSmithKline Group of Companies